Risk analysis of use of different classes of antidepressants on subsequent dementia: A nationwide cohort study in Taiwan

PLoS ONE

Volumn 12, Issue 4, 2017, Pages

  Then, Chee Kin ^a,b   Chi, Nai Fang ^b,c   Chung, Kuo Hsuan ^a,d   Kuo, Lynn ^e   Liu, Kao Hui ^c,f   Hu, Chaur Jong ^b,c   Shen, Shing Chuan ^b   Lin, Yen Kuang ^g  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e UNIVERSITY OF CONNECTICUT   (United States)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DOXEPIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SEROTONIN ANTAGONIST AND REUPTAKE INHIBITOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TETRACYCLIC ANTIDEPRESSANT AGENT; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VENLAFAXINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; RISK ASSESSMENT; RISK FACTOR; TAIWAN; CASE CONTROL STUDY; MIDDLE AGED;

ADULT; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; TAIWAN;

EID: 85017281749     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0175187     Document Type: Article

References (56)

1. Sun Y, Lee HJ, Yang SC, Chen TF, Lin KN, Lin CC, et al. A Nationwide Survey of Mild Cognitive Impairment and Dementia, Including Very Mild Dementia, in Taiwan. PloS one. 2014; 9(6).
2. MacQueen GM, Memedovich KA. Cognitive dysfunction in major depression and bipolar disorder: Assessment and treatment options. Psychiatry and clinical neurosciences. 2017; 71(1):18-27. https:// doi.org/10.1111/pcn.12463 PMID: 27685435
3. Chen R, Wei L, Hu Z, Qin X, Copeland JR, Hemingway H. Depression in older people in rural China. Archives of internal medicine. 2005; 165(17):2019-25. https://doi.org/10.1001/archinte.165.17.2019PMID: 16186473
4. Chong MY, Tsang HY, Chen CS, Tang TC, Chen CC, Yeh TL, et al. Community study of depression in old age in Taiwan: prevalence, life events and socio-demographic correlates. The British journal of psychiatry: the journal of mental science. 2001; 178(1):29-35.
5. da Silva J, Goncalves-Pereira M, Xavier M, Mukaetova-Ladinska EB. Affective disorders and risk of developing dementia: systematic review. The British journal of psychiatry: the journal of mental science. 2013; 202(3):177-86.
6. Byers AL, Yaffe K. Depression and risk of developing dementia. Nature reviews Neurology. 2011; 7 (6):323-31. https://doi.org/10.1038/nrneurol.2011.60 PMID: 21537355
7. Muliyala KP, Varghese M. The complex relationship between depression and dementia. Ann Indian Acad Neur. 2010; 13:69-73.
8. Bennett S, Thomas AJ. Depression and dementia: cause, consequence or coincidence? Maturitas. 2014; 79(2):184-90. https://doi.org/10.1016/j.maturitas.2014.05.009 PMID: 24931304
9. Byers AL, Yaffe K. Depression and risk of developing dementia. Nature Reviews Neurology. 2011; 7 (6):323-31. https://doi.org/10.1038/nrneurol.2011.60 PMID: 21537355
10. Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf PA, Au R. Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology. 2010; 75(1):35-41. https://doi.org/10.1212/WNL.0b013e3181e62138 PMID: 20603483
11. Li G, Wang LY, Shofer JB, Thompson ML, Peskind ER, McCormick W, et al. Temporal relationship between depression and dementia: findings from a large community-based 15-year follow-up study. Archives of general psychiatry. 2011; 68(9):970-7. https://doi.org/10.1001/archgenpsychiatry.2011.86PMID: 21893662
12. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Archives of general psychiatry. 2006; 63(5):530-8. https://doi.org/10.1001/archpsyc.63.5.530 PMID: 16651510
13. Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, et al. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Archives of neurology. 2003; 60(5):753-9. https://doi.org/10. 1001/archneur.60.5.753 PMID: 12756140
14. Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J Neurol Neurosur Ps. 2004; 75(12):1662-6.
15. Butters MA, Young JB, Lopez O, Aizenstein HJ, Mulsant BH, Reynolds CF 3rd, et al. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues in clinical neuroscience. 2008; 10(3):345-57. PMID: 18979948
16. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Archives of general psychiatry. 2009; 66(8):848-56. https://doi.org/10.1001/archgenpsychiatry.2009.81 PMID: 19652124
17. Wu CS, Shau WY, Chan HY, Lee YC, Lai YJ, Lai MS. Utilization of antidepressants in Taiwan: a nationwide population-based survey from 2000 to 2009. Pharmacoepidemiology and drug safety. 2012; 21 (9):980-8. https://doi.org/10.1002/pds.3255 PMID: 22511574
18. Yang D, Chen M, Russo-Neustadt A. Antidepressants are neuroprotective against nutrient deprivation stress in rat hippocampal neurons. The European journal of neuroscience. 2012; 36(5):2573-87. https://doi.org/10.1111/j.1460-9568.2012.08187.x PMID: 22779752
19. Shilyansky C, Williams LM, Gyurak A, Harris A, Usherwood T, Etkin A. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. Lancet Psychiat. 2016; 3(5):425-35.
20. Andrews PW, Thomson JA Jr., Amstadter A, Neale MC. Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good. Frontiers in psychology. 2012; 3:117.
21. Schmitt JA, Ramaekers JG, Kruizinga MJ, van Boxtel MP, Vuurman EF, Riedel WJ. Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man. Journal of psychopharmacology. 2002; 16(3):207-14. https://doi.org/10.1177/026988110201600303 PMID: 12236626
22. Bartholoma P, Erlandsson N, Kaufmann K, Rossler OG, Baumann B, Wirth T, et al. Neuronal cell death induced by antidepressants: lack of correlation with Egr-1, NF-kappa B and extracellular signal-regulated protein kinase activation. Biochemical pharmacology. 2002; 63(8):1507-16. PMID: 11996893
23. Schipke CG, Heuser I, Peters O. Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex. J Psychiatr Res. 2011; 45(2):242-8. https://doi.org/10. 1016/j.jpsychires.2010.06.005 PMID: 20619420
24. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. British medical journal. 2011; 343.
25. Hodge JM, Wang Y, Berk M, Collier FM, Fernandes TJ, Constable MJ, et al. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function. Biological psychiatry. 2013; 74(1):32-9. https://doi.org/10.1016/j.biopsych.2012.11.003 PMID: 23260229
26. Xia Z, Karlsson H, DePierre JW, Nassberger L. Tricyclic antidepressants induce apoptosis in human T lymphocytes. International journal of immunopharmacology. 1997; 19(11-12):645-54. PMID: 9669204
27. Li Y, Couch L, Higuchi M, Fang JL, Guo L. Mitochondrial dysfunction induced by sertraline, an antidepressant agent. Toxicological sciences: an official journal of the Society of Toxicology. 2012; 127 (2):582-91.
28. Chen S, Xuan J, Wan L, Lin H, Couch L, Mei N, et al. Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicological sciences: an official journal of the Society of Toxicology. 2014; 137(2):404-15.
29. Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 2011; 378(9789):403-11. https://doi.org/10.1016/S0140-6736(11)60830-1 PMID: 21764118
30. Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, et al. Sertraline for the treatment of depression in Alzheimer disease. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry. 2010; 18(2):136-45.
31. Madhusoodanan S, Alexeenko L, Sanders R, Brenner R. Extrapyramidal symptoms associated with antidepressants-a review of the literature and an analysis of spontaneous reports. Annals of clinical psychiatry: official journal of the American Academy of Clinical Psychiatrists. 2010; 22(3):148-56.
32. National Health Research Institute. National Health Insurance Research Database(NHIRD). Available at: http://nhird.nhri.org.tw/en/index.html. Accessed December 19, 2015.
33. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2013. Oslo, 2012.
34. JC N. Tricyclic and tetracyclic drugs. 4th ed. In: The American Psychiatric Publishing Textbook of Psychopharmacology: Schatzberg AF, Nemeroff CB (Ed), American Psychiatric Publishing, Washington, DC 2009.
35. Howland RH. A benefit-risk assessment of agomelatine in the treatment of major depression. Drug safety. 2011; 34(9):709-31. https://doi.org/10.2165/11593960-000000000-00000 PMID: 21830835
36. Nierenberg AA, Ostacher MJ, Huffman JC, Ametrano RM, Fava M, Perlis RH. A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder. Journal of occupational and environmental medicine. 2008; 50(4):428-36. https://doi.org/10.1097/JOM.0b013e31816b5034 PMID: 18404015
37. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. Journal of clinical epidemiology. 1994; 47(11):1245-51. PMID: 7722560
38. Berger AK, Fratiglioni L, Forsell Y, Winblad B, Backman L. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology. 1999; 53(9):1998-2002. PMID: 10599771
39. Chen PJ, Ganguli M, Mulsant BH, DeKosky ST. The temporal relationship between depressive symptoms and dementia-A community-based prospective study. Archives of general psychiatry. 1999; 56 (3):261-6. PMID: 10078504
40. Chung CM, Kuo TM, Chiang SL, Wang ZH, Hung CC, Lane HY, et al. Antidepressants in association with reducing risk of oral cancer occurrence: a nationwide population-based cohort and nested casecontrol studies. Oncotarget. 2016; 7(10):11687-95. https://doi.org/10.18632/oncotarget.7049 PMID: 26840257
41. Cheng BH, Chen PC, Yang YH, Lee CP, Huang KE, Chen VC. Effects of depression and antidepressant medications on hip fracture: A population-based cohort study in Taiwan. Medicine. 2016; 95(36): e4655. https://doi.org/10.1097/MD.0000000000004655 PMID: 27603358
42. Hsieh YH, Chiu WC, Lin CF, Chan HL, Liang HY, Lee Y, et al. Antidepressants and Gastric Cancer: A Nationwide Population-Based Nested Case-Control Study. PloS one. 2015; 10(11):e0143668. https:// doi.org/10.1371/journal.pone.0143668 PMID: 26606417
43. Malberg JE, Duman RS. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2003; 28(9):1562-71.
44. Chen H, Pandey GN, Dwivedi Y. Hippocampal cell proliferation regulation by repeated stress and antidepressants. Neuroreport. 2006; 17(9):863-7. https://doi.org/10.1097/01.wnr.0000221827.03222.70PMID: 16738477
45. Gardarsdottir H, Heerdink ER, van Dijk L, Egberts AC. Indications for antidepressant drug prescribing in general practice in the Netherlands. Journal of affective disorders. 2007; 98(1-2):109-15. https://doi. org/10.1016/j.jad.2006.07.003 PMID: 16956665
46. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, et al. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. Eur J Neurol. 2009; 16(9):968-81. https://doi.org/10. 1111/j.1468-1331.2009.02748.x PMID: 19708964
47. Chou R, Huffman LH, American Pain S, American College of P. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Annals of internal medicine. 2007; 147(7):505-14. PMID: 17909211
48. Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American pain Society/American college of physicians clinical practice guideline. Annals of internal medicine. 2007; 147(7):505-14. PMID: 17909211
49. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Db Syst Rev. 2012(12).
50. Moret C, Briley M. Antidepressants in the treatment of fibromyalgia. Neuropsychiatric disease and treatment. 2006; 2(4):537-48. PMID: 19412502
51. Hsiao FY, Peng LN, Lin MH, Chen LK. Dose-responsive effect of psychotropic drug use and subsequent dementia: a nationwide propensity score matched case-control study in Taiwan. Journal of the American Medical Directors Association. 2014; 15(7):509-13. https://doi.org/10.1016/j.jamda.2014.02.009 PMID: 24685407
52. Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative Use of Strong Anticholinergics and Incident Dementia A Prospective Cohort Study. Jama Intern Med. 2015; 175 (3):401-7. https://doi.org/10.1001/jamainternmed.2014.7663 PMID: 25621434
53. Lee CW, Lin CL, Sung FC, Liang JA, Kao CH. Antidepressant treatment and risk of dementia: a population-based, retrospective case-control study. The Journal of clinical psychiatry. 2016; 77(1):117-22. https://doi.org/10.4088/JCP.14m09580 PMID: 26845268
54. Mossello E, Boncinelli M, Caleri V, Cavallini MC, Palermo E, Di Bari M, et al. Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease? Dement Geriatr Cogn. 2008; 25 (4):372-9.
55. Kessing LV, Sondergard L, Forman JL, Andersen PK. Antidepressants and dementia. Journal of affective disorders. 2009; 117(1-2):24-9. https://doi.org/10.1016/j.jad.2008.11.020 PMID: 19138799
56. Sheline YI, West T, Yarasheski K, Swarm R, Jasielec MS, Fisher JR, et al. An antidepressant decreases CSF Abeta production in healthy individuals and in transgenic AD mice. Sci Transl Med. 2014; 6(236):236re4. https://doi.org/10.1126/scitranslmed.3008169 PMID: 24828079